Year-over-year articles
ABIOSA PHARMA AS
9 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 918 832 424
Another loss-making year
Comparing Årsregnskap 2025 with 2024 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -250 NOK → -491 NOK. Equity -11.9k NOK → -12.4k NOK.
Another loss-making year
Comparing Årsregnskap 2024 with 2023 for ABIOSA PHARMA AS. Net result -2 486 NOK → -250 NOK. Equity -11.7k NOK → -11.9k NOK.
Another loss-making year
Comparing Årsregnskap 2023 with 2022 for ABIOSA PHARMA AS. Net result -300 NOK → -2 486 NOK. Equity -9 184 NOK → -11.7k NOK.
Another loss-making year
Comparing Årsregnskap 2022 with 2021 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -300 NOK → -300 NOK. Equity -8 884 NOK → -9 184 NOK.
Another loss-making year
Comparing Årsregnskap 2021 with 2020 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -298 NOK → -300 NOK. Equity -8 584 NOK → -8 884 NOK.
Another loss-making year
Comparing Årsregnskap 2020 with 2019 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -971 NOK → -298 NOK. Equity -8 286 NOK → -8 584 NOK.
Shrank 100% on revenue, slipped into loss
Comparing Årsregnskap 2019 with 2018 for ABIOSA PHARMA AS. Revenue 1 194 NOK → 0 NOK (-100.0%). Net result +22.2k NOK → -971 NOK. Equity -7 315 NOK → -8 286…
Grew 100% on revenue
Comparing Årsregnskap 2018 with 2017 for ABIOSA PHARMA AS. Revenue 597 NOK → 1 194 NOK (+100.0%). Net result +15.1k NOK → +22.2k NOK. Equity 14.9k NOK → -7…
First published accounts
First year in the published series for ABIOSA PHARMA AS (2017). No prior-year comparative in this dataset.